Publications relating to health R&D
Publications written or commissioned by the Observatory
This paper highlights four key areas of concern based on the Observatory’s analysis: the allocation of research grants in health, the availability of health researchers, the distribution and availability of higher education institutions with disciplines relevant to health research, and the achievement of global health R&D targets. It advocates for proactive measures to address these concerns and illustrates the value of tracking and analysing health research and development in a regular and comprehensive manner.
Research and development landscape for childhood cancer: a 2023 perspective
This summary addresses the challenges and obstacles in the research and development (R&D) landscape for childhood cancer medicines. It draws on data from the Observatory to highlight the gaps and barriers in this field. It advocates for increased investment in both research and clinical architecture for paediatric oncology.
Resource allocation for biomedical research: analysis of investments by major funders
This paper reports on the methods and analysis of grants for biomedical research by 10 major funders of health research, exploring what is being funded, by whom and where. It also describes the automated data mining approach used to classify text-based data (titles or abstracts) into health categories when this categorization is not readily available.
Biomedical research; what gets funded where?
This editorial reports on the key findings from the new analysis of health products pipeline and situates it within other analysis by the Observatory and their implications on decisions for new investments on health research.
HARPS series on the Global Observatory on Health R&D
Developed following a WHO Call for papers to inform the establishment of the Observatory. The objective of the series is to provide global stakeholders with up-to-date knowledge on methods, analyses and applications to draw from when developing future investment decisions for new health R&D.